CompaniesCytomedix

Cytomedix

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (8)
View all

Total Trials

8

As Lead Sponsor

7

As Collaborator

1

Total Enrollment

150

By Phase

PHASE4: 2NA: 5

By Status

TERMINATED: 5WITHDRAWN: 2UNKNOWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00762138
NCT02248077
NCT02940587
Hover over trial bars to see details

Recent Trials

NCT02940587Lead Sponsor
Effectiveness of Aurix Therapy in Venous Leg Ulcers
PHASE4Withdrawn
Started: Feb 28, 2015 · Completed: Feb 28, 2018
NCT02248077Lead Sponsor
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
PHASE4Withdrawn
Started: Oct 31, 2014
NCT01816633Lead Sponsor
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
NATerminated
3 participants
Started: Oct 31, 2013 · Completed: Jan 31, 2015
NCT01817543Lead Sponsor
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
NATerminated
2 participants
Started: Oct 31, 2013 · Completed: Jan 31, 2015
NCT01816672Lead Sponsor
Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.
NATerminated
4 participants
Started: Apr 30, 2013 · Completed: Jul 31, 2015
View all 8 trials →
Funding History (20)
8-K
Oct 10, 2025
Filing
D
Aug 4, 2025
Filing
8-K
May 15, 2025
Filing
D
Sep 23, 2024
Filing
8-K
Sep 19, 2024
Filing
8-K
Jun 27, 2024
Filing
8-K
Jun 11, 2024
Filing
D
May 22, 2024
Filing
8-K
May 21, 2024
Filing
8-K
Apr 16, 2024
Filing